Raphael Pharmaceutical Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $45.0K | $19.0K | $230.0K | $288.0K | $153.0K | $95.0K | $50.0K |
| Accounts Receivable | $2.0K | $2.0K | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $51.0K | $25.0K | $237.0K | $331.0K | $422.0K | $323.0K | — |
| Property, Plant & Equipment | $2.0K | $2.0K | $2.0K | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $2.0K | $2.0K | — | — | — |
| Total Assets | $53.0K | $27.0K | $239.0K | $333.0K | $422.0K | $323.0K | — |
| Liabilities | |||||||
| Accounts Payable | $163.0K | $125.0K | $69.0K | — | — | — | — |
| Total Current Liabilities | $1.5M | $769.0K | $132.0K | $227.0K | $294.0K | $366.0K | — |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $1.5M | $769.0K | $132.0K | $227.0K | $294.0K | $366.0K | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $-10.2M | $-8.9M | $-7.4M | $-6.0M | $-2.7M | $-1.0M | — |
| Total Stockholders' Equity | $-1.4M | $-742.0K | $107.0K | $106.0K | $128.0K | $-43.0K | $208.0K |